The US Environmental Protection Agency (EPA) proposed changes to rollback safeguards against air emissions of ethylene oxide (EtO), a highly carcinogenic gas used to sterilise about half of all medical devices in the USA. Announced March 17, 2026, the proposed changes would, among other things, relax round-the-clock emissions monitoring requirements for about 90 commercial sterilisation facilities.
The Lancet Oncology published a clinical update in Oncology on 19 Mar 2026.
The item focuses on US EPA proposes easing ethylene oxide emission standards.
Review the original article for the full source wording and details.